You are here
Home > RX List

Search RXList.com© Drug Database

Enter drug's generic or brand name below. Results will appear here. Note: all drug related information obtained on this page is provided by RX List.

Using the RX LIST database:
(1) Enter the drug name in the search box below and hit ENTER
(2) The rx list web site will open here with the drug search completed. Next, scroll down the page to locate the link to the drug you are searching for and then click on the link.

Alphabetical Listing of drugs

a b c d e f g h i j k l m
n o p q r s t u v w x y z

Drug Description

Cinobac®
(cinoxacin)

DESCRIPTION

Cinobac® (Cinoxacin, USP) is a synthetic antibacterial agent for oral administration. Cinoxacin, quinolone, is 1-ethyl-1,4-dihydro-4-oxo-[1,3] dioxolo [4,5-g] cinnoline-3-carboxylic acid and occurs as white or very light-yellow, needle-shaped crystals. Cinobac (cinoxacin) is available as 250-(0.95 mmol) and 500-mg (1.9 mmol) capsules. These capsules also contain D & C Yellow No. 10, F D & C Blue No. 1, F D & C Red No. 3, F D & C Yellow No. 6, gelatin, silicon dioxide, silicone fluid, sodium lauryl sulfate, starch, titanium dioxide, and other inactive ingredients.

The molecular formula is C12H10N2O5 and the molecular weight is 262.22.

Indications & Dosage

INDICATIONS

Cinobac (cinoxacin) is indicated for the treatment of initial and recurrent urinary tract infections in adults caused by the following susceptible microorganisms: Escherichia coli, Proteus mirabilis, Proteus vulgaris, Klebsiella species (including K.pneumoniae), and Enterobacter species.

Cinobac (cinoxacin) is effective in preventing urinary tract infections for up to 5 months in women with a history of recurrent urinary tract infections.

In vitro susceptibility testing should be performed prior to administration of the drug and, when clinically indicated, during treatment.

DOSAGE AND ADMINISTRATION

The usual adult dosage for the treatment of urinary tract infections is 1 g daily, administered orally in 2 or 4 divided doses (500 mg b.i.d. or 250 mg q.i.d. respectively) for 7 to 14 days. Doses should be administered at least 2 hours before or 2 hours after antacids containing magnesium or aluminum, as well as sucralfate, metal cations such as iron, and multivitamin preparations with zinc or Videx (didanosine) chewable tablets or the pediatric powder for oral solution. Although susceptible organisms may be eradicated within a few days after therapy has begun, the full treatment course is recommended.

Impaired Renal Function: When renal function is impaired, a reduced dosage must be employed. After an initial dose of 500 mg, a maintenance dosage schedule should be used (see table).

MAINTENANCE DOSAGE GUIDE
FOR PATIENTS WITH RENAL IMPAIRMENT
Creatinine
Clearance
mL/min/1.73 m²
Renal
Function
Dosage
>80 Normal 500 mg
b.i. d.
80-50 Mild
Impairment
250 mg
t.i. d.
50-20 Moderate
Impairment
250 mg
b.i.d.


RX List

thpxl